Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 73

Results For "CEO"

1712 News Found

Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
News | March 09, 2023

Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants

Resomer used in commercial 3D-printed implants for both soft and hard tissue applications


Sun Pharma completes acquisition of Concert Pharmaceuticals
News | March 07, 2023

Sun Pharma completes acquisition of Concert Pharmaceuticals

The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market


Venus Remedies joins India AMR Innovation Hub
News | March 07, 2023

Venus Remedies joins India AMR Innovation Hub

lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid


Aptar appoints Julie Xing to its Board of Directors
People | March 07, 2023

Aptar appoints Julie Xing to its Board of Directors

Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.


Aster DM Healthcare appoints Purana H Deepti as Additional Director
People | March 06, 2023

Aster DM Healthcare appoints Purana H Deepti as Additional Director

She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.


5 crore health records of individuals linked to their ABHA for anytime access
Policy | March 01, 2023

5 crore health records of individuals linked to their ABHA for anytime access

With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)


Venus Remedies awarded Saudi GMP approval for all its production facilities in Baddi
Drug Approval | February 28, 2023

Venus Remedies awarded Saudi GMP approval for all its production facilities in Baddi

The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region


Porton Advanced and Yinjia Biosciences partner to enhance CDMO technology platform
Biotech | February 27, 2023

Porton Advanced and Yinjia Biosciences partner to enhance CDMO technology platform

Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.


Novartis appoints Gilbert Ghostine Chairman-Designate of Sandoz Board of Directors
News | February 24, 2023

Novartis appoints Gilbert Ghostine Chairman-Designate of Sandoz Board of Directors

Ghostine has served as CEO of Geneva-based Firmenich, the world's largest privately owned perfume and taste company, since 2014.